Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central neurotransmitter receptors and membrane proteins represent a diverse and extensive group of proteins that facilitate communication within the central nervous system (CNS). This category includes G protein-coupled receptors (GPCRs), ligand-gated ion channels (ionotropic receptors), and various membrane transporters responsible for the uptake and recycling of neurotransmitters (IUPHAR/BPS Guide to PHARMACOLOGY, 2024). These proteins are fundamental to physiological processes such as mood regulation, memory formation, and motor coordination. They function by converting chemical signals—neurotransmitters like glutamate, GABA, dopamine, and serotonin—into electrical or biochemical responses in neurons (StatPearls, 2023). Dysregulation of these systems is implicated in a vast array of conditions, including Alzheimer's disease, schizophrenia, and clinical depression (Purves et al., 2001). While these proteins are the primary targets for many of the most successful drugs in neurology and psychiatry, the term itself is a broad classification rather than a specific molecular entity. Pharmacological interventions targeting these proteins include agonists, antagonists, and reuptake inhibitors designed to modulate synaptic activity. Due to the complexity of the CNS, drugs hitting these targets often face challenges related to blood-brain barrier penetration and off-target effects.
This category encompasses various mechanisms including receptor agonism, antagonism, allosteric modulation, and transport inhibition across multiple distinct protein families.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central neurotransmitter receptors and membrane proteins.